Study of S1B-408 in Women With Orgasmic Dysfunction
Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-30
Target enrollment:
Participant gender:
Summary
This is the first clinical trial of S1B-408 in women with sexual dysfunction. A prior 4-week trial in premenopausal women with Hypoactive Sexual Desire Disorder showed that orgasmic function improved with Lorexys (TM). This pilot trial tests for improvement in orgasmic function, safety, and tolerability of a different but related test article.